Tonix Pharmaceuticals Holding Corp.
Initiate clinical trials of TNX-2100
Delivered after the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 8 Feb 2021
- Due
- 31 Dec 2021
- Delivered
- Q1 2022
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“We expect clinical trials of TNX-2100 can be initiated, upon FDA clearance of the IND application, in the second half of 2021.”
What we found
Evidence strength A What the grades mean
The company initiated the first-in-human clinical study for TNX-2100 in the first quarter of 2022, which is after the second half of 2021 deadline.
-
A Tonix Pharmaceuticals Holding Corp. 10-K filed 2022-03-14
“Tonix received IND clearance in the fourth quarter of 2021 and initiated enrollment in a first-in-human study of TNX-2100 in the first quarter of 2022.” ✓ confirmed on the page
-
A Tonix Pharmaceuticals Holding Corp. 10-Q filed 2022-05-09
“Tonix initiated a first-in-human, dose-finding clinical study for TNX-2100, a diagnostic skin test to measure delayed-type hypersensitivity (DTH) reaction to SARS-CoV-2, in early January 2022.” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Initiate
- Deliverable
- Clinical trials of TNX-2100
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: upon FDA clearance of the IND application
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Tonix Pharmaceuticals Holding Corp.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-TNXP-023269 · Corrections policy